2023³â ´ëÇѺҾÈÀÇÇÐȸ Ãß°èÇмú´ëȸ : 2023-10-13
±³À°ÀÏÀÚ : 2023-10-13
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü
±³À°ÁÖÁ¦ : "2023³â ´ëÇѺҾÈÀÇÇÐȸ Ãß°èÇмú´ëȸ "
ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺҾÈÀÇÇÐȸ (ÀÌ»çÀåÁ¦)
´ã´çÀÚ : ´ëÇѺҾÈÀÇÇÐȸ »ç¹«±¹
¿¬¶ôó : 031-787-7434
À̸ÞÀÏ : benzcl500@naver.com
±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í "- »çÀüµî·Ïºñ : [ȸ¿øÀü¹®ÀÇ 4¸¸¿ø], [ºñȸ¿øÀü¹®ÀÇ 5¸¸¿ø], [±ºÀü¹®ÀÇ,°øº¸ÀÇ,Àü°øÀÇ 3¸¸¿ø], [Æò»ýȸ¿ø¸éÁ¦]
- ÇöÀåµî·Ïºñ : [ȸ¿øÀü¹®ÀÇ 5¸¸¿ø], [ºñȸ¿øÀü¹®ÀÇ 6¸¸¿ø], [±ºÀü¹®ÀÇ,°øº¸ÀÇ,Àü°øÀÇ 4¸¸¿ø], [Æò»ýȸ¿ø¸éÁ¦]"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:30~09:50 Suicide attempts in patients with amyotrophic lateral sclerosis: an analysis of the Korean National Health Insurance Database ¹ÚÇü±Ù(¿ï»êÀÇ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:50~10:10 Development of Explainable Artificial Intelligence-Based Computer-Aided Diagnostic System for Diagnosing the Patients with Major Depressive Disorder ÀÌÀº°æ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:10~10:30 The effect of VR-based mindfulness training in patients with anxiety disorders ÀüÈ«½Ä(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:30~10:50 Poor sleep quality in older adults and alterations in the global brain network: a resting state fMRI study Á¤À̳»(¿ï»êÀÇ´ë)
Åä·Ð 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:50~11:00 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 11:10~11:30 Understanding the Precise Concept of PTSD ¹ÚÁÖ¾ð(°è¿äº´¿ø)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 11:30~11:50 The Updates on Pharmacotherapy for PTSD ±è¿øÇü(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 11:50~12:10 Stabilization and Exposure Therapy in Patients with PTSD ½É¹Î¿µ(±¹¸³Á¤½Å°Ç°¼¾ÅÍ)
Åä·Ð 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 12:10~12:20 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 12:30~12:55 Effectiveness of vortioxetine in patients with MDD and anxiety symptom ¾ÈÈ£¿µ(°è¿äº´¿ø)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 12:55~13:20 Unique efficacy of vortioxetine on emotional blunting and anhedonia ÀÌ°¼ö(Â÷ÀÇ°úÇдë)
Åä·Ð 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 13:20~13:30 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 13:40~14:05 Presence and futures of Precision Medicine in depression and anxiety ³ë´ë¿µ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 14:05~14:30 Electrophysiological approaches for the Precision Medicine in depression À̽Âȯ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 14:30~14:55 Electrophysiological approaches for the Precision Medicine in anxiety ±è¹ÎÀç(¼øõÇâÀÇ´ë)
Åä·Ð 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 14:55~15:05 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 15:15~15:40 Clinical trials and findings: Glutamate modulators for anxiety disorders ÀåÁø±¸(¸íÁöº´¿ø)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 15:40~16:05 Clinical trials and findings: Psychedelic therapies for anxiety disorders ¿ÀÁöÈÆ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 16:05~16:30 Clinical trials and findings: Cannabinoid-related agents for anxiety disorders ³ë´ë¿µ(ÇѸ²ÀÇ´ë)
Åä·Ð 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 16:30~16:45 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 09:30~09:55 Extinction of generalized fear memory using stimulation of dopamine neurons Á¶¿ë»ó( °í·Á´ëÇб³ ½É¸®Çаú)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 09:55~10:20 Traumatic memory in patients with PTSD and phobia ÃÖ¼öÈñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 10:20~10:45 Somatics in patients with PTSD ÇãÈÞÁ¤(°¡Å縯ÀÇ´ë)
Åä·Ð 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 10:45~11:00 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 11:10~11:30 Social stigma surrounding mental health issues ±è°¡Àº( ÀÌÈÀÇ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 11:30~11:50 Community trauma ÀÌÈÄ ¹Ìµð¾î¿Í ±¹°¡ÀÇ ¿ªÇÒ Á¤½½¾Æ( Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 11:50~12:10 Educating Communities: Promoting Mental Health Literacy for Enhanced Well-being ½Å¿ë¿í(¿ï»êÀÇ´ë)
Åä·Ð 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 12:10~12:20 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 12:30~12:55 Holistic Evaluation for Anxiety Disorder Treatment Option: Focused on Sertraline °µîÇö(¼¿ïƯº°½Ã º¸¶ó¸Åº´¿ø)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 12:55~13:20 Clinical and functional benefits of use Sertraline in Anxiety disorder ¾È¸íÈñ(¼¿ï¾Æ»êº´¿ø)
Åä·Ð 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 13:20~13:30 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 13:40~14:05 Anxiety in suicidal patients ¾çÁ¤ÈÆ(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 14:05~14:30 Comorbid anxiety in bipolar disorder ¹®Àº¼ö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 14:30~14:55 Different types of anxiety symptoms in schizophrenia ¿À»óÈÆ(À»ÁöÀÇ´ë)
Åä·Ð 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 14:55~15:05 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:15~15:35 ¹üºÒ¾ÈÀå¾ÖÀÇ ÃÊ±â ¹× À¯Áö ¾à¹°Ä¡·á Àü·« ±è¹Î°æ(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:35~15:55 ¹üºÒ¾ÈÀå¾ÖÀÇ Á¤½ÅÄ¡·á Àü·« ¹ÚõÀÏ(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 15:55~16:15 ¹üºÒ¾ÈÀå¾ÖÀÇ Ä¡·á ¹ÝÀÀÀÌ ºÒÃæºÐÇÑ °æ¿ì ¹× °øÁ¸ÁúȯÀÌ Á¸ÀçÇÏ´Â °æ¿ì Ä¡·á Àü·« ¼ÁØÈ£(¿¬¼¼¿øÁÖÀÇ´ë)
±âŸ 10¿ù 13ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 16:15~16:45 2023 ¹üºÒ¾ÈÀå¾Ö Ä¡·áÁöħ¼ °³Á¤ÆÇ °³¹ß °øûȸ ()